<DOC>
	<DOCNO>NCT00669994</DOCNO>
	<brief_summary>This trial evaluate effective safe Cipro XR treat female patient sign symptom low urinary tract infection . After 3 day treatment , patient evaluate determine signs/symptoms disappear infect bacteria eliminate .</brief_summary>
	<brief_title>Trial Evaluate Efficacy Safety Cipro® XR Treating Female Patients With Lower Urinary Tract Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Nonpregnant , nonlactating female outpatient age 18 44 year ( inclusive ) Patients least two follow clinical sign symptom uUTI : Dysuria Frequency Urgency Suprapubic pain Patients onset symptom &lt; 72 hour prior study entry Patients one positive pretreatment cleancatch midstream urine culture enrollment study , define &gt; 10000 CFU/mL ( study drug treatment permit prior availability urine culture result ) Positive leukocyte esterase ( LE ) ( 1+ great ) utilize urine dipstick method analysis Patients willing give write informed consent Cultures must perform pretreatment cleancatch midstream urine ( MSU ) specimens Males Women pregnant , nursing , use two medically accept , effective method birth control Patients know suspected hypersensitivity quinolones Patients unable take oral medication reason Patients asymptomatic bacteriuria Patients complicate UTI , define : clinical syndrome characterize development systemic local sign symptom fever ( &gt; 38.3°C/101°F orally ) , chill , malaise , flank pain , back pain , costovertebral angle ( CVA ) pain tenderness Symptoms outline inclusion criterion occur presence functional anatomical abnormality urinary tract presence urinary catheterization Patients symptoms UTI within 4 week prior present episode Patients onset symptom &gt; 72 hour prior study entry Patients three episode UTI past 12 month Patients evidence factor predispose development UTIs , include calculus , stricture , primary renal disease ( e.g . polycystic renal disease ) , neurogenic bladder Patients receive systemic antimicrobial therapy within 48 hour prior entry Patients neutrophil count &lt; 1000/mm3 , CD4 &lt; 200/mm3 condition associate significant depression host defense ; HIV test mandatory Patients require concomitant systemic antibacterial therapy agent specify protocol Patients previous history tendinopathy associate fluoroquinolones Patients diagnose rapidly fatal underlying disease ( death expect within six month ) Patients require concomitant use theophylline Patients previously enrol clinical study Patients take investigational drug last 30 day</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>UTI</keyword>
	<keyword>Urinary Tract Infection</keyword>
</DOC>